Your position:m.limatoxi.com >> EN >> EN >> Formulation >> AstraZeneca Merck Jointly Release the Results of the Phase 3 Clinical Trial of Olaparib >> article
 
AstraZeneca Merck Jointly Release the Results of the Phase 3 Clinical Trial of Olaparib
Editor:xuezhe    Clicks:0    Date:2022-6-26 15:46:11
Keyword: AstraZeneca
Healthoo Information:
AstraZeneca Merck Jointly Release the Results of the Phase 3 Clinical Trial of Olaparib
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Phase III Study of AstraZenecas Innovative Therapy was Successful! A L...
  • AstraZeneca is Considering Buying Its Partner Mereo BioPharma
  • AstraZeneca adjusted business strategy in China
  • AstraZeneca started to build manufacturing fa...
  • AstraZeneca to acquire a generics company&nbs...
  • AstraZeneca to build new manufacturing facili...
  • AstraZeneca begins construction work at Zhang...
  • AstraZeneca planned to built a industry ...
  • AstraZeneca Outsources to China
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map